Laser Beam Therapeutics (LBT) offers a treatment solution to improve the prognosis in cases of acute myocardial infarction (MI). Safe and noninvasive, the LBT treatment uses external laser activation to mobilize stem cells to enter the circulatory system. These activated stem cells focus on the MI scar and work to reverse the scarring process. The CardioZ16 Laser Device is a laser that is brought into contact with the skin over a marrow-containing bone. The laser's light is used to stimulate the marrow to speed tissue repair, even in areas of the body that are located far from the treated bone. The LBT solution is showing promising initial results in minimizing scarring in acute myocardial infarction as well as in gastroenterology and neurological conditions such as Alzheimer's disease.